A young child is brought to the emergency department with severe dehydration secondary to acute diarrhea and vomiting. Therapeutic management of this child will begin with which intervention?
Clear liquids, 1 to 2 ounces at a time.
Administration of antidiarrheal medication.
Oral rehydration solution (ORS).
Intravenous fluids.
The Correct Answer is C
The correct answer is choice C: Oral rehydration solution (ORS).
Choice A rationale:
Clear liquids, 1 to 2 ounces at a time, might not be sufficient to adequately rehydrate a child with severe dehydration. Clear liquids lack the necessary electrolytes and glucose content to effectively combat dehydration and replace lost fluids.
Choice B rationale:
Administration of antidiarrheal medication is not the initial step in managing severe dehydration caused by acute diarrhea and vomiting. Antidiarrheal medications can slow down the gastrointestinal motility, which may exacerbate the problem by delaying the elimination of the causative agent and prolonging the dehydration.
Choice C rationale:
Oral rehydration solution (ORS) is the recommended initial intervention for managing severe dehydration caused by acute diarrhea and vomiting. ORS contains the appropriate balance of electrolytes (sodium, potassium, chloride) and glucose to replace lost fluids and electrolytes, thereby helping to rehydrate the child effectively. It is absorbed even when digestion is impaired due to the illness.
Choice D rationale:
Intravenous fluids might be necessary if the child's condition is very severe and oral intake cannot be maintained. However, it's not the first-line intervention. Oral rehydration is preferred whenever feasible because it is less invasive and can be administered even in mild to moderate dehydration cases.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
The correct answer is choice D: Verbalizing the importance of monitoring for medication side effects.
Choice A rationale:
Allowing the adolescent to make decisions about whether or not to take medication is important, but it is not the priority nursing goal for a 14-year-old diagnosed with Graves' disease. The priority is ensuring proper medication management and monitoring to control the thyroid dysfunction and prevent potential complications.
Choice B rationale:
Relieving constipation might be a consideration, but it is not the priority nursing goal for a 14-year-old diagnosed with Graves' disease. The primary focus is on addressing the thyroid-related issues and providing appropriate education and support to the adolescent.
Choice C rationale:
Developing alternative educational goals is not the priority nursing goal for a 14-year-old diagnosed with Graves' disease. While education is important, the immediate concern is managing the medical condition and ensuring the adolescent's well-being.
Choice D rationale:
Verbalizing the importance of monitoring for medication side effects is the priority nursing goal for a 14-year-old diagnosed with Graves' disease. Graves' disease is a thyroid disorder that requires medication management, typically involving antithyroid medications or other interventions. Monitoring for medication side effects ensures the adolescent's safety and helps to prevent adverse reactions or complications. It also empowers the adolescent to be vigilant about their health and medication regimen.
Correct Answer is ["C","D"]
Explanation
The correct answers are choices C. Novolin R, and D. NovoLog.
Choice A rationale:
Novolin N is an intermediate-acting insulin, not rapid or short acting. It has a slower onset and longer duration of action, making it unsuitable for rapid blood sugar control.
Choice B rationale:
Lantus is a long-acting insulin that provides basal insulin coverage and has a relatively steady effect over 24 hours. It is not rapid or short acting and is used to provide a baseline level of insulin, not for immediate blood sugar control.
Choice C rationale:
Novolin R, also known as regular insulin, is a short-acting insulin with an onset of about 30 minutes and a peak effect around 2 to 3 hours. It is often used to cover mealtime blood sugar elevations and is suitable for short-term blood sugar control.
Choice D rationale:
NovoLog is a rapid-acting insulin analog with an onset of about 15 minutes and a peak effect within 1 to 2 hours. It is designed to mimic the body's rapid insulin release after meals, making it effective for controlling postprandial blood sugar levels.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.